Halozyme Therapeutics Inc. (HALO)

$ 64.04
   
  • Change Today:
    $1.15
  • 52 Week High: $70.14
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 150
  • Market Cap: $9,305m
  • RiskGrade: 189

HALO Overview

1 Day Chart (12-08-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,251.76 723.94 550.00¢ 11.6 n/a n/a n/a 0.0%
31-Dec-26 1,477.69 892.48 726.67¢ 8.8 0.3 +32% n/a 0.0%
31-Dec-27 1,680.97 1,083.81 923.50¢ 6.9 0.3 +27% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 64.04
Change Today $ 1.15
% Change 1.83 %
52 Week High $70.14
52 Week Low $42.57
Volume 150
Shares Issued 145.30m
Market Cap $9,305m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-Aug-2025

Time Volume / Share Price
16:00 158,874 @ $64.04
15:59 100 @ $64.04
15:59 100 @ $64.04
15:59 100 @ $64.04
15:59 200 @ $64.05

Top of Page